Ketoconazole 2% shampoo in the treatment of tinea versicolor: A multicenter, randomized, double-blind, placebo-controlled trial

被引:27
|
作者
Lange, DS
Richards, HM
Guarnieri, J
Humeniuk, JM
Savin, RC
Reyes, BA
Hickman, J
Pariser, DM
Pariser, RJ
Sherertz, EF
Grossman, RM
Gisoldi, EM
Klausner, MA
机构
[1] Janssen Pharmaceut, Dept Med Affairs, Titusville, NJ 08560 USA
[2] Upstate Clin Res, Greer, SC USA
[3] Savin Dermatol Ctr, New Haven, CT USA
[4] Int Dermatol Res, Miami, FL USA
[5] Educ & Res Fdn, Lynchburg, VA USA
[6] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[7] Virginia Clin Res, Norfolk, VA USA
[8] Wake Forest Univ, Bowman Gray Sch Med, Dermatol Clin Studies Ctr, Winston Salem, NC USA
[9] Johnson & Johnson Consumer Prod Inc, Skillman, NJ 08558 USA
关键词
D O I
10.1016/S0190-9622(98)70267-1
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Tinea versicolor is a common superficial fungal infection caused by a lipophilic yeast. This chronically recurring opportunistic infection is especially prevalent in tropical and semitropical regions. The topical short-term application of ketoconazole 2% shampoo may provide effective and safe therapy for tinea versicolor. Objective: The purpose of this study was to evaluate the efficacy and safety of a single application (1 day) versus three daily applications (3 days) of ketoconazole 2% shampoo versus placebo shampoo in the treatment of mycologically confirmed tinea versicolor. Methods: Three hundred twelve patients were included in the primary analyses for this 31-day study. Global evaluation scores were measured on days 10 and 31 with a 5-point scale (1 = healed to 5 = worsening), and a cellophane tape test was done at baseline and days 3, 10, and 31. Efficacy was assessed by clinical response, defined as both a global evaluation score of 1 (healed) and a negative cellophane tape test on day 31. Signs and symptoms of tinea versicolor (scaling, itching, erythema, hypopigmentation, hyperpigmentation) also were evaluated at baseline, day 10, and day 31 with a 4-point scale (0 = absent to 3 = severe). Results: Both regimens of ketoconazole shampoo were significantly (P <.001) more effective than placebo for rate of clinical response, global evaluation scores, and mycologic outcomes (cellophane tape test). The clinical response rates at day 31 were 73%, 69%, and 5% for the 3-day ketoconazole, 1-day ketoconazole, and placebo groups, respectively. The difference in the efficacy of the two ketoconazole treatment regimens was not statistically significant. There were no significant differences between any of the treatment groups in the number of patients who experienced adverse events. No serious adverse events occurred and no patient withdrew from the trial prematurely because of an adverse event. Conclusion: Ketoconazole 2% shampoo, used as a single application or daily for 3 days, is safe and highly effective in the treatment of tinea versicolor.
引用
收藏
页码:944 / 950
页数:7
相关论文
共 50 条
  • [31] Adalimumab in Severe and Acute Sciatica A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Genevay, Stephane
    Viatte, Sebastien
    Finckh, Axel
    Zufferey, Pascal
    Balague, Federico
    Gabay, Cem
    [J]. ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2339 - 2346
  • [32] Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial
    Fleischer, David M.
    Burks, A. Wesley
    Vickery, Brian P.
    Scurlock, Amy M.
    Wood, Robert A.
    Jones, Stacie M.
    Sicherer, Scott H.
    Liu, Andrew H.
    Stablein, Donald
    Henning, Alice K.
    Mayer, Lloyd
    Lindblad, Robert
    Plaut, Marshall
    Sampson, Hugh A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) : 119 - U184
  • [33] Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial
    Furyk, Jeremy S.
    Chu, Kevin
    Banks, Colin
    Greenslade, Jaimi
    Keijzers, Gerben
    Thom, Ogilvie
    Torpie, Tom
    Dux, Carl
    Narula, Rajan
    [J]. ANNALS OF EMERGENCY MEDICINE, 2016, 67 (01) : 86 - 95
  • [34] Multicenter randomized double-blind placebo-controlled glucosamine discontinuation trial in osteoarthritis.
    Cibere, J
    Esdaile, JM
    Thorne, A
    Singer, J
    Kopec, JA
    Canvin, J
    Robinson, DB
    Pope, J
    Hong, P
    Grant, E
    Ionescu, M
    Poole, AR
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S576 - S577
  • [35] Meniett Device in Meniere Disease: Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Russo, Francesca Yoshie
    Yann Nguyen
    De Seta, Daniele
    Bouccara, Didier
    Sterkers, Olivier
    Ferrary, Evelyne
    Bernardeschi, Daniele
    [J]. LARYNGOSCOPE, 2017, 127 (02): : 470 - 475
  • [36] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    [J]. CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [37] Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial
    Aimi, Masahito
    Komazawa, Yoshinori
    Hamamoto, Naoharu
    Yamane, Yuko
    Furuta, Koichiro
    Uchida, Yasushi
    Yano, Shozo
    Ota, Miwa
    Oguro, Hiroaki
    Miyake, Tatsuya
    Sugimoto, Toshitsugu
    Naora, Kohji
    Nagi, Seiichi
    Ishihara, Shunji
    Goubaru, Yoshiyuki
    Kinoshita, Yoshikazu
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S739 - S739
  • [38] A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
    Miller, AE
    Morgante, LA
    Buchwald, LY
    Coyle, PK
    Krupp, LB
    Doscher, CA
    Lublin, FD
    Knobler, RL
    Trantas, F
    Kelley, L
    Smith, CR
    LaRocca, N
    Lopez, S
    [J]. NEUROLOGY, 1997, 48 (02) : 312 - 314
  • [39] Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial of Mesalamine for the Prevention of Recurrence of Diverticulitis
    Kruis, Wolfgang
    Eisenbach, Thomas
    Loehr, Hanns
    Mueser, Moritz
    Tan, Gie T.
    Lukas, Milan
    Vich, Tomas
    Bunganic, Ivan
    Pokrotnieks, Juris
    Derova, Jelena
    Kondrackiene, Jurate
    Safadi, Rifaat
    Tuculanu, Daniel
    Tulassay, Zsolt
    Banai, Janos
    Dilger, Karin
    Greinwald, Roland
    Mohrbacher, Ralf
    Spiller, Robin C.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S139 - S139
  • [40] Pilocarpine spray for the treatment of xerostomia: a randomized, double-blind, placebo-controlled trial
    Fragoso Motta, Ana Carolina
    Marques, Vanessa Tonetto
    Cabral, Fernanda Fortes
    dos Santos Polvora, Tabata Larissa
    de Macedo, Leandro Dorigan
    Alencar Ramos Inocenttini, Lara Maria
    Ferreira Duarte, Maira Peres
    Oliveira, Fabiola Reis
    Rocha, Eduardo Melani
    de Freitas, Osvaldo
    Tirapelli, Camila
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S319 - S319